In human studies of lymphedema families, heterozygous inactivating missense mutations have been detected in the tyrosine kinase–encoding region of Flt4 (VEGFR-3) [82], indicating that some lymphedema patients have dysfunctional lymphatics due to defective VEGFR-3 signaling. This evidence concerns the gene FLT4 and lymphedema.